TRUQAP

Medicinal product

(Invented) name

TRUQAP

Active substance (s)

Kapivasertibas

Strength

160 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01EX27, capivasertib

Marketing authorisation holder

AstraZeneca AB, Švedija

Date of authorisation

2024-06-17

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Kapivasertibas	160 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
113926	100042	1100042	lizdinė plokštelė	N64		Receptinis	EU/1/24/1820/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-06-17	Registruotas